FindTrial
Sign In

Comparing the difference of the survival between Duraloc and Pinnacle acetabular component in total hip arthroplasty: a 10 years follow-up study

Comparing the difference of the survival between Duraloc and Pinnacle acetabular component in total hip arthroplasty: a 10 years follow-up study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034641
Enrollment
Unknown
Registered
2020-07-12
Start date
2020-07-13
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end-stage hip disease

Interventions

Pinnacle group:Using Pinnacle acetabular implant
Duraloc group:Using Duraloc acetabular implant

Sponsors

Department of Orthopedics, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patients who underwent total hip arthroplasty more than 10 years ago; 2. patients underwent total hip arthroplasty with Duraloc or Pinnacle acetabular implant.

Exclusion criteria

Exclusion criteria: 1. patients who underwent total hip arthroplasty with less than 10 years; 2. patients who underwent total hip arthroplasty with non-Pinnacle or Duraloc implants.

Design outcomes

Primary

MeasureTime frame
Harris hip function score;X ray examination; monochromatic energy reconstructed CT;implant survival rate;—

Secondary

MeasureTime frame
complications;—

Countries

China

Contacts

Public ContactZeng Yi

West China Hospital, Sichuan University

zengyigd@126.com+86 18980602289

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026